SAB Biotherapeutics, Inc. Profile Avatar - Palmy Investing

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that…

Biotechnology
US, Sioux Falls [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of SABS's Analysis
CIK: 1833214 CUSIP: 78397T103 ISIN: US78397T2024 LEI: - UEI: -
Secondary Listings
SABS has no secondary listings inside our databases.